Increased IL-6 levels in the patients’ sera are indeed associated with dramatic changes in the metabolism of cancer patients because it influences the metabolism of adipocytes, hepatocytes and striated muscle cells, and eventually induces cancer cachexia and wasting [56,57,58]. The gene discussed is IL6; the disease is cancer.